The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
pneumococcal vaccine polyvalent
4 marketed package NDCs · 2 active manufacturers
What changed in the last 90 days
Every detected change for pneumococcal vaccine polyvalent, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Pneumovax 23Aug 2, 2026Mfr exitedMerck Sharp & Dohme LLC · pneumococcal vaccine polyvalent
- pneumococcal vaccine polyvalentAug 2, 2026Mfr exitedMSD Ireland (Carlow) · pneumococcal vaccine polyvalent
- pneumococcal vaccine polyvalentJul 22, 2026Mfr enteredMSD Ireland (Carlow) · pneumococcal vaccine polyvalent
- Pneumovax 23Jul 22, 2026Mfr enteredMerck Sharp & Dohme LLC · pneumococcal vaccine polyvalent
Same drug class
Other molecules FDA puts in Inactivated Pneumococcal Vaccine, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Pneumococcal vaccine polyvalent in shortage right now?
- No. FDA does not currently list Pneumococcal vaccine polyvalent in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Pneumococcal vaccine polyvalent?
- 2 companies have marketed Pneumococcal vaccine polyvalent in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.